Study Finds Diabetes Drug Semaglutide May Prevent Worsening Anxiety and Depression

Recent research reveals that semaglutide, a GLP-1 diabetes medication, may help prevent the worsening of anxiety and depression in patients with type 2 diabetes. This is significant as individuals with diabetes have nearly double the risk of depression compared to the general population. Future studies should explore semaglutide's dual benefits on metabolic and mental health to guide integrated treatment approaches.